IDEXX Laboratories IDXX releases its next round of earnings this Friday, July 30. Get the latest predictions in Benzinga's essential guide to the company's Q2 earnings report.
Net Income, Earnings, And Earnings Per Share
Earnings and especially earnings per share (EPS) are useful measures of a company's profitability. Total earnings, which is also referred to as net income, equals total revenue minus total expenses. EPS equals to net income divided by the number of shares outstanding.
Earnings And Revenue
Based on management's projections, IDEXX Laboratories analysts model for earnings of $2.04 per share on sales of $782.99 million. IDEXX Laboratories reported a per-share profit of $1.72 when it published results during the same quarter last year. Sales in that period totaled $637.59 million.
What Are Analyst Estimates And Earnings Surprises, And Why Do They Matter?
Analysts who cover this company will publish forward-looking estimates of its revenue and EPS each quarter. Averaging together every EPS and revenue prediction that each analyst makes about a company in a quarter yields the "consensus estimates." A company posting earnings or revenue above or below the consensus estimate is known as an "earnings surprise" and may move the stock by a considerable margin.
The analyst consensus estimate would represent a 18.6% increase in the company's earnings. Sales would be up 22.8% on a year-over-year basis. The company's reported EPS has stacked up against analyst estimates in the past like this:
Quarter | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 |
---|---|---|---|---|
EPS Estimate | 1.71 | 1.40 | 1.42 | 1.16 |
EPS Actual | 2.35 | 1.76 | 1.69 | 1.72 |
Revenue Estimate | 737.38 M | 681.02 M | 669.45 M | 589.98 M |
Revenue Actual | 777.71 M | 720.94 M | 721.79 M | 637.59 M |
Want Real-Time Earnings Calendar Updates?
Benzinga consistently updates its earnings calendars to stay up-to-date with the latest company earnings reports. Check out the full earnings calendar list updated in real-time by following this link.
Stock Performance
Shares of IDEXX Laboratories were trading at $695.58 as of July 28. Over the last 52-week period, shares are up 75.85%. Given that these returns are generally positive, long-term shareholders are probably satisfied going into this earnings release.
Do not be surprised to see the stock move on comments made during its conference call. IDEXX Laboratories is scheduled to hold the call at 08:30:00 ET and can be accessed here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.